 |
This template is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks. |
|
 NA |
This template does not require a rating on the project's quality scale. |
|
|
|
|
Very large template[edit]
This template seems to be rather large and therefore confusing. Couldn't it be split somehow? --ἀνυπόδητος (talk) 17:31, 9 October 2009 (UTC)
Labetalol[edit]
In this template this drugs would act as agonist and antagonist; since its role as Beta-blocker, I would correct it. Emigiorg (talk) 14:36, 31 July 2012 (UTC)
- Thanks for correcting that error! --ἀνυπόδητος (talk) 17:46, 31 July 2012 (UTC)
Semi-protected edit request on 15 September 2014[edit]
 |
This edit request has been answered. Set the |answered= or |ans= parameter to no to reactivate your request. |
NikoGoro (talk) 05:22, 15 September 2014 (UTC)
Done Anon126 (notify me of responses! / talk / contribs) 05:50, 15 September 2014 (UTC)
Semi-protected edit request on 28 April 2015[edit]
|
This edit request has been answered. Set the |answered= or |ans= parameter to no to reactivate your request. |
B2-agonist Olodaterol NikoGoro (talk) 07:34, 28 April 2015 (UTC)
Not done: it's not clear what changes you want to be made. Please mention the specific changes in a "change X to Y" format. EoRdE6(Come Talk to Me!) 14:44, 28 April 2015 (UTC)
Semi-protected edit request on 16 December 2015[edit]
|
This edit request has been answered. Set the |answered= or |ans= parameter to no to reactivate your request. |
Xylometazoline is a α1 agonist too. 193.233.52.241 (talk) 08:24, 16 December 2015 (UTC)
Added Seppi333 (Insert 2¢) 09:44, 16 December 2015 (UTC)
